Today, a clinical study was started at the University Hospital UMC Utrecht (The Netherlands) in which the disruptive echo robot of the Dutch start-up Corbotics will be validated for effectiveness and safety on a group of 300 patients in total. This so-called multi-center study also involves the Dutch hospitals LUMC, OLVG, Haga, Isala and Catharina.

This project, “BBE-MVP”, is co-sponsored by the EU with the Kansen voor West 3 Grant.